⌘K

Login Start Free

Home/Filings/4/0001213900-24-016026

4//SEC Filing

HULL ANDREW 4

Accession 0001213900-24-016026

CIK 0001728328other

View on SEC.gov Company Profile

Filed

Feb 21, 7:00 PM ET

Accepted

Feb 22, 1:38 PM ET

Size

4.6 KB

Accession

0001213900-24-016026

Insider Transaction Report

Form 4

Period: 2024-02-21

InMed Pharmaceuticals Inc.INM

Director

Transactions

Purchase
Common Stock
2024-02-21$0.39/sh+37,500$14,625→ 38,258 total

Documents

1 file

4
ownership.xmlPrimary

Issuer

InMed Pharmaceuticals Inc.

CIK 0001728328

Entity typeother

Related Parties

1

filerCIK 0001818252

Filing Metadata

Form type: 4
Filed: Feb 21, 7:00 PM ET
Accepted: Feb 22, 1:38 PM ET
Size: 4.6 KB

View on SEC.gov